Overview

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is effective in treating painful HIV-associated neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
NeurogesX
Treatments:
Capsaicin